Selenium 用于 冠状动脉疾病(CAD)
C 证据 来自小型研究的证据有限,但存在一些积极信号。SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).
结论
SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).
Key Study Findings
研究人群: patients with depression
研究人群: hypertension patients
Key Statistics
5
研究数量
10000
受试者
Mixed
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 55 mcg/day
- cardiovascularantioxidant:
- 100-200 mcg/day
上限: 400 mcg/day (risk of selenosis above this level)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Neutral | -- |
| None | -- | Positive | -- |
最佳服用时间: With meals
Safety & Side Effects
已报告的副作用
- ⚠ Selenosis at high doses (garlic breath odor, hair/nail loss, nausea)
- ⚠ GI discomfort at moderate-high doses
- ⚠ Potential increased type 2 diabetes risk at high supplemental doses
已知相互作用
- ● Cisplatin and other chemotherapy drugs (may affect efficacy)
- ● Statins (may enhance antioxidant effects)
- ● CoQ10 (synergistic cardiovascular benefit — KiSel-10 combination)
可耐受最高摄入量: 400 mcg/day (risk of selenosis above this level)
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Selenium help with 冠状动脉疾病(CAD)?
How much Selenium should I take for 冠状动脉疾病(CAD)?
Are there side effects of Selenium?
How strong is the evidence for Selenium and 冠状动脉疾病(CAD)?
Related Evidence
其他成分用于 冠状动脉疾病(CAD)
Selenium 用于其他健康状况
References
- [1] Mark C Houston. J Clin Hypertens (Greenwich). 2011. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. doi:10.1111/j.1751-7176.2011.00489.x PubMed
- [2] Michael Maes et al.. Neuro Endocrinol Lett. 2011. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway … PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。